Cozaar and Neoplasm recurrence - a phase IV clinical study of FDA data

Summary:

Neoplasm recurrence is reported as a side effect among people who take Cozaar (losartan potassium), especially for people who are female, 60+ old, also take Vitamin D3, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Neoplasm recurrence when taking Cozaar. It is created by eHealthMe based on reports of 43,582 people who have side effects when taking Cozaar from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Neoplasm recurrence?

Neoplasm recurrence (reoccurrence of tumour) is found to be associated with 363 drugs and 494 conditions by eHealthMe. Check the latest studies of Neoplasm recurrence.

On Jul, 12, 2026

43,582 people reported to have side effects when taking Cozaar.
Among them, 18 people (0.04%) have Neoplasm recurrence.

Among these 18 people:

What is the gender of people who have Neoplasm recurrence when taking Cozaar? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Neoplasm recurrence when taking Cozaar? *

What are other drugs people take besides Cozaar? *

Vitamin D3: 7 people, 38.89%
Synthroid: 6 people, 33.33%
Folic Acid: 5 people, 27.78%
Benadryl: 5 people, 27.78%
Symbicort: 5 people, 27.78%
Humalog: 4 people, 22.22%
Nystatin: 4 people, 22.22%
Methotrexate Sodium: 4 people, 22.22%
Methocarbamol: 4 people, 22.22%
Metformin Hydrochloride: 4 people, 22.22%

What are other side effects people have besides Neoplasm recurrence? *

Malaise (a feeling of general discomfort or uneasiness): 5 people, 27.78%
Infection: 4 people, 22.22%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 4 people, 22.22%
Neoplasm Malignant (cancer tumour): 4 people, 22.22%
Limb Injury: 4 people, 22.22%
Joint Swelling: 4 people, 22.22%
Malignant Neoplasm Of Eye (cancer tumour of eye): 4 people, 22.22%
Drowsiness: 4 people, 22.22%
Fall: 4 people, 22.22%
Therapeutic Response Unexpected: 4 people, 22.22%

What are the existing conditions these people have? *

Anaemia (lack of blood): 7 people, 38.89%
High Blood Cholesterol: 7 people, 38.89%
Pain: 5 people, 27.78%
Cardiac Disorder: 5 people, 27.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 27.78%
Blood Iron Decreased: 4 people, 22.22%
Depression: 4 people, 22.22%
Diabetes: 4 people, 22.22%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 4 people, 22.22%
Hypersensitivity: 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and have Neoplasm recurrence?

- Check whether Neoplasm recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cozaar:

Cozaar (45,124 reports)

Browse all side effects of Cozaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm recurrence:

Neoplasm recurrence (363 drugs)

Browse all the conditions that are associated with Neoplasm recurrence:

Neoplasm recurrence (494 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Cozaar) and Cozaar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.